Cargando…

Pre-Clinical Safety and Efficacy Evaluation of Amytrap, a Novel Therapeutic to Treat Alzheimer’s Disease

Alzheimer’s disease (AD) is the most common cause of dementia. Amyloid-β (Aβ(42)) is implicated in AD pathogenesis. We have designed a non-immune based proprietary therapeutic, called Amytrap, a conjugate containing a retro-inverso peptide, polyethylene glycol, and human serum albumin. Amytrap not o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gandbhir, Omkar, Sundaram, Pazhani
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2019
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597960/ https://www.ncbi.nlm.nih.gov/pubmed/31259305 http://dx.doi.org/10.3233/ADR-190107

Ejemplares similares

‘Amytrapper’, a Novel Immobilized Sepharose API Matrix, Removes Amyloid-β from Circulation in vitro
por: Gandbhir, Omkar, et al.
Publicado: (2019)

Novel API Coated Catheter Removes Amyloid-β from Plasma of Patients with Alzheimer’s Disease
por: Chhipa, Rishi Raj, et al.
Publicado: (2021)

Zinc Therapy in Early Alzheimer’s Disease: Safety and Potential Therapeutic Efficacy
por: Squitti, Rosanna, et al.
Publicado: (2020)

Novel Therapeutics in Alzheimer's Disease
por: Sabbagh, Marwan, et al.
Publicado: (2012)

Clinical efficacy and safety of donepezil in the treatment of Alzheimer’s disease in Chinese patients
por: Zhang, Nan, et al.
Publicado: (2018)

Memantine: a review of studies into its safety and efficacy in treating Alzheimer’s disease and other dementias
por: Thomas, Stuart J, et al.
Publicado: (2009)

A novel FOXP3 knockout-humanized mouse model for pre-clinical safety and efficacy evaluation of Treg-like cell products
por: Sato, Yohei, et al.
Publicado: (2023)

Therapeutic efficacy of novel memantine nitrate MN‐08 in animal models of Alzheimer’s disease
por: Wu, Liangmiao, et al.
Publicado: (2021)

Clinical efficacy and safety evaluation of favipiravir in treating patients with severe fever with thrombocytopenia syndrome
por: Yuan, Yang, et al.
Publicado: (2021)

Pre-clinical safety and therapeutic efficacy of a plant-based alkaloid in a human colon cancer xenograft model
por: Freeling, Jessica L., et al.
Publicado: (2022)

Glucose dysregulation in pre-clinical Alzheimer’s disease
por: Connolly, Niamh M. C., et al.
Publicado: (2019)

Memantine: efficacy and safety in mild-to-severe Alzheimer’s disease
por: Tampi, Rajesh R, et al.
Publicado: (2007)

Recombinant pre-miR-29b for Alzheimer´s disease therapeutics
por: Pereira, Patrícia A., et al.
Publicado: (2016)

Development of pre-clinical and clinical models to predict the efficacy and safety of vaginal microbicides
por: Herold, Betsy C
Publicado: (2006)

Clinical Efficacy and Safety of Eculizumab for Treating Myasthenia Gravis
por: Xiao, Hai, et al.
Publicado: (2021)

Evaluation of the efficacy and safety of vilazodone for treating major depressive disorder
por: Zhang, Xiao-Fei, et al.
Publicado: (2015)

Efficacy and Safety Evaluation of Mometasone Furoate in Treating Ocular Inflammation
por: Lage, Nayara Almeida, et al.
Publicado: (2023)

Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma
por: Bownes, Laura V., et al.
Publicado: (2022)

Clinical activity and safety of Pembrolizumab in Ipilimumab pre-treated patients with uveal melanoma
por: Karydis, Ioannis, et al.
Publicado: (2016)

A novel approach to treat peri implantitis with the help of PRF
por: Shah, Rashmi, et al.
Publicado: (2017)

A Novel Therapeutic Approach to Treat Alzheimer’s Disease by Neurotrophic Support During the Period of Synaptic Compensation
por: Baazaoui, Narjes, et al.
Publicado: (2018)

Anti-microRNAs as Novel Therapeutic Agents in the Clinical Management of Alzheimer's Disease
por: Zhao, Yuhai, et al.
Publicado: (2016)

Safety and efficacy of sargramostim (GM‐CSF) in the treatment of Alzheimer's disease
por: Potter, Huntington, et al.
Publicado: (2021)

Therapeutic implication of chimeric antigen receptor T-cell therapy for head and neck squamous cell carcinoma
por: Pazhani, Jayanthi, et al.
Publicado: (2023)

Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial
por: Teng, Edmond, et al.
Publicado: (2022)

Currently Used Methods to Evaluate the Efficacy of Therapeutic Drugs and Kidney Safety
por: Huang, Hung-Jin, et al.
Publicado: (2023)

Evaluation of the safety and efficacy of radiofrequency ablation for treating benign thyroid nodules
por: Tang, Xiaoyin, et al.
Publicado: (2017)

Clinical evidence of human pathogens implicated in Alzheimer’s disease pathology and the therapeutic efficacy of antimicrobials: an overview
por: Catumbela, Celso S. G., et al.
Publicado: (2023)

Evaluation of Efficacy and Safety Using Low Dose Radiation Therapy with Alzheimer’s Disease: A Protocol for Multicenter Phase II Clinical Trial
por: Kim, Dong-Yun, et al.
Publicado: (2023)

Novel therapeutic target against Alzheimer
por: LeBlanc, Andrea C.
Publicado: (2017)

Pre‐clinical evidences for the efficacy of tryptanthrin as a potent suppressor of skin cancer
por: Shankar G., Mohan, et al.
Publicado: (2019)

Leptin: A Novel Therapeutic Target in Alzheimer's Disease?
por: Beccano-Kelly, Dayne, et al.
Publicado: (2012)

Alzheimer's Disease and Cognitive Frailty: Novel Therapeutic Technologies
por: D'Onofrio, Grazia, et al.
Publicado: (2016)

Exosomes: a novel therapeutic target for Alzheimer’s disease?
por: Cai, Zhi-You, et al.
Publicado: (2018)

Advances in developing novel therapeutic strategies for Alzheimer’s disease
por: Cao, Jiqing, et al.
Publicado: (2018)

Translating the biology of aging into novel therapeutics for Alzheimer disease
por: Hara, Yuko, et al.
Publicado: (2019)

Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review
por: Yu, Tien-Wei, et al.
Publicado: (2021)

Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma
por: Singh, Anil R., et al.
Publicado: (2020)

Safety and tolerability of lumbar puncture for the evaluation of Alzheimer's disease
por: Baldaranov, Dobri, et al.
Publicado: (2023)

The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer’s disease: protocol for a randomized controlled trial
por: Chua, Ka-Kit, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tfgalu5idcpmaev99qg3g7m05j